Skip to main content
Fig. 5 | Immunity & Ageing

Fig. 5

From: B-1 derived anti-Thy-1 B cells in old aged mice develop lymphoma/leukemia with high expression of CD11b and Hamp2 that different from TCL1 transgenic mice

Fig. 5

12 mo TC–CD5 down ATA B spleen++ cells similar to old aged TC–ATA B lymphoma/leukemia. TC+ Tg ATA B lymphoma/leukemia are NF-kB1 high. Old aged TC– ATA B are CD11b++CD22++, CD24low, and Hamp2++ generation, and V8-12 with Vk19 AGcA MZ B are 12 mo Hamp2+ and old age generated macrophage++ with intestinal tumor. A and B. 12 mo TC–CD5– ATA B with spleen++ generate similar to old aged TC–CD5–ATA B tumor. TC+Tg ATA B CLL/lymphoma are higher NF-kB and TCL1 induced miR21 and miR155 and down miR29. C TC– lymphoma/leukemia showed CD11b++CD22++ and generate Hamp2++ (TC–ZAP70– are more IL10 and IL-6, and TC–ZAP70+ are high IL-22R) with iron down, as USF2+, TFR+, FPN–. D TC– ATA B lymphoma/leukemia generated high Hamp2 and CD44++CD24low. Human V2-5 positive papers, as kidney, Breast cancer, Pancreatic cancer, SARS-CoV-2, and SLE. Breast cancer are CD44++CD24lo. E Some ATA B tumor showed together with high myeloid cells (CD11b+Gr-1+) [13], and VH8-12/Vk19 AGcA generate MZ B with Hamp2+ in 12 mo, then old aged generate macrophages++ in spleen with intestine/color tumor++

Back to article page